Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C G Moertel

Showing results (221-230 of 251) with videos related to

Pageof 26
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1994
Controlled evaluation of three drug combination regimens versus fluorouracil alone for the therapy of advanced gastric cancer. North Central Cancer Treatment GroupS A Cullinan, C G Moertel, H S Wieand, et al.
Archives of Surgery (Chicago, Ill. : 1960)|July 1, 1990
Adjuvant therapy for resectable colorectal carcinoma with fluorouracil administered by portal vein infusion. A study of the Mayo Clinic and the North Central Cancer Treatment GroupR W Beart, C G Moertel, H S Wieand, et al.
Cancer|April 1, 1993
Combined doxorubicin and alpha-interferon therapy of advanced hepatocellular carcinomaC G Kardinal, C G Moertel, H S Wieand, et al.
Cancer|May 15, 1990
Breakout V. Concerns of the clinical investigatorC G Moertel, J L Wilson, G H Christ, et al.
The New England Journal of Medicine|January 28, 1982
A clinical trial of amygdalin (Laetrile) in the treatment of human cancerC G Moertel, T R Fleming, J Rubin, et al.
Cancer Chemotherapy Reports|November 1, 1975
Urinary excretion of polyamines by patients with advanced malignancyT P Waalkes, C W Gehrke, D C Tormey, et al.
Cancer|August 15, 1991
DNA ploidy and cell kinetic measurements as predictors of recurrence and survival in stages B2 and C colorectal adenocarcinomaT E Witzig, C L Loprinzi, N J Gonchoroff, et al.
The New England Journal of Medicine|April 12, 1984
The physician's responsibility toward hopelessly ill patientsS H Wanzer, S J Adelstein, R E Cranford, et al.
The New England Journal of Medicine|March 30, 1989
The physician's responsibility toward hopelessly ill patients. A second lookS H Wanzer, D D Federman, S J Adelstein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1989
Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo ClinicJ A Laurie, C G Moertel, T R Fleming, et al.
Pageof 26

Showing results (221-230 of 251) with videos related to

Sort By:
Pageof 26
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1994
Controlled evaluation of three drug combination regimens versus fluorouracil alone for the therapy of advanced gastric cancer. North Central Cancer Treatment GroupS A Cullinan, C G Moertel, H S Wieand, et al.
Archives of Surgery (Chicago, Ill. : 1960)|July 1, 1990
Adjuvant therapy for resectable colorectal carcinoma with fluorouracil administered by portal vein infusion. A study of the Mayo Clinic and the North Central Cancer Treatment GroupR W Beart, C G Moertel, H S Wieand, et al.
Cancer|April 1, 1993
Combined doxorubicin and alpha-interferon therapy of advanced hepatocellular carcinomaC G Kardinal, C G Moertel, H S Wieand, et al.
Cancer|May 15, 1990
Breakout V. Concerns of the clinical investigatorC G Moertel, J L Wilson, G H Christ, et al.
The New England Journal of Medicine|January 28, 1982
A clinical trial of amygdalin (Laetrile) in the treatment of human cancerC G Moertel, T R Fleming, J Rubin, et al.
Cancer Chemotherapy Reports|November 1, 1975
Urinary excretion of polyamines by patients with advanced malignancyT P Waalkes, C W Gehrke, D C Tormey, et al.
Cancer|August 15, 1991
DNA ploidy and cell kinetic measurements as predictors of recurrence and survival in stages B2 and C colorectal adenocarcinomaT E Witzig, C L Loprinzi, N J Gonchoroff, et al.
The New England Journal of Medicine|April 12, 1984
The physician's responsibility toward hopelessly ill patientsS H Wanzer, S J Adelstein, R E Cranford, et al.
The New England Journal of Medicine|March 30, 1989
The physician's responsibility toward hopelessly ill patients. A second lookS H Wanzer, D D Federman, S J Adelstein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1989
Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo ClinicJ A Laurie, C G Moertel, T R Fleming, et al.
Pageof 26